Literature DB >> 14594104

Modeling interindividual variation in physiological factors used in PBPK models of humans.

Paul S Price1, Rory B Conolly, Christine F Chaisson, Elizabeth A Gross, John S Young, Eric T Mathis, Douglas R Tedder.   

Abstract

Modeling interindividual variation in internal doses in humans using PBPK models requires data on the variation in physiological parameters across the population of interest. These data should also reflect the correlations between the values of the various parameters in a person. In this project, we develop a source of data for human physiological parameters where (1) the parameter values for an individual are correlated with one another, and (2) values of parameters capture interindividual variation in populations of a specific gender, race, and age range. The parameters investigated in this project include: (1) volumes of selected organs and tissues; (2) blood flows for the organs and tissues; and (3) the total cardiac output under resting conditions and average daily inhalation rate. These parameters are expressed as records of correlated values for the approximately 30,000 individuals evaluated in the NHANES III survey. A computer program, Physiological Parameters for PBPK Modeling (P3M), is developed that allows records to be retrieved randomly from the database with specification of constraints on age, sex, and ethnicity. P3M is publicly available. The database and accompanying software provide a convenient tool for parameterizating models of interindividual variation in human pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594104

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  70 in total

1.  Application of pharmacokinetic modelling for 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure assessment.

Authors:  P Ruiz; L L Aylward; M Mumtaz
Journal:  SAR QSAR Environ Res       Date:  2014-11-14       Impact factor: 3.000

2.  Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.

Authors:  Sabine Pilari; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-07-27       Impact factor: 2.745

3.  Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.

Authors:  Elin Svensson; Jan-Stefan van der Walt; Karen I Barnes; Karen Cohen; Tamara Kredo; Alwin Huitema; Jean B Nachega; Mats O Karlsson; Paolo Denti
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

4.  Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.

Authors:  Feng Yang; Xianping Tong; D Gail McCarver; Ronald N Hines; Daniel A Beard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-07       Impact factor: 2.745

Review 5.  To scale or not to scale: the principles of dose extrapolation.

Authors:  Vijay Sharma; John H McNeill
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 6.  Probabilistic exposure analysis for chemical risk characterization.

Authors:  Kenneth T Bogen; Alison C Cullen; H Christopher Frey; Paul S Price
Journal:  Toxicol Sci       Date:  2009-02-17       Impact factor: 4.849

7.  A Bayesian meta-analysis on published sample mean and variance pharmacokinetic data with application to drug-drug interaction prediction.

Authors:  Menggang Yu; Seongho Kim; Zhiping Wang; Stephen Hall; Lang Li
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

8.  A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells.

Authors:  Huanhuan Joyce Chen; Paula Miller; Michael L Shuler
Journal:  Lab Chip       Date:  2018-07-10       Impact factor: 6.799

9.  Pumpless microfluidic platform for drug testing on human skin equivalents.

Authors:  Hasan Erbil Abaci; Karl Gledhill; Zongyou Guo; Angela M Christiano; Michael L Shuler
Journal:  Lab Chip       Date:  2015-02-07       Impact factor: 6.799

10.  A physiologically-based recirculatory meta-model for nasal fentanyl in man.

Authors:  Richard N Upton; David J R Foster; Lona L Christrup; Ola Dale; Kristin Moksnes; Lars Popper
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-19       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.